Page last updated: 2024-08-17

aspartic acid and gabapentin

aspartic acid has been researched along with gabapentin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's1 (11.11)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Porter, RJ1
Dooley, DJ; Fink, K; Göthert, M; Meder, W1
Dager, SR; Friedman, SD; Layton, ME1
Arnold, DL; Caramanos, Z; Cashman, NR; Genge, A; Kalra, S1
Coderre, TJ; Kumar, N; Lefebvre, CD; Yu, JS1
Brawek, B; Feuerstein, TJ; Löffler, M; Weyerbrock, A1
Carlson, PJ; Hasler, G; Preuss, N; Shen, J; van der Veen, JW1
Chen, SR; Pan, HL; Shao, JY; Zhou, JJ1

Trials

2 trial(s) available for aspartic acid and gabapentin

ArticleYear
Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment.
    Depression and anxiety, 2001, Volume: 14, Issue:4

    Topics: Acetates; Adult; Amines; Arousal; Aspartic Acid; Brain; Cyclohexanecarboxylic Acids; Double-Blind Method; Energy Metabolism; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Infusions, Intravenous; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Panic; Panic Disorder; Treatment Outcome

2001
Low single dose gabapentin does not affect prefrontal and occipital gamma-aminobutyric acid concentrations.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:12

    Topics: Adult; Amines; Analysis of Variance; Anticonvulsants; Aspartic Acid; Choline; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Prefrontal Cortex; Young Adult

2013

Other Studies

7 other study(ies) available for aspartic acid and gabapentin

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Mechanisms of action of new antiepileptic drugs.
    Epilepsia, 1989, Volume: 30 Suppl 1

    Topics: Acetamides; Acetates; Amines; Aminocaproates; Aminopyridines; Anti-Anxiety Agents; Anticonvulsants; Aspartic Acid; Benzodiazepines; Benzodiazepinones; Clobazam; Cyclohexanecarboxylic Acids; Dibenzocycloheptenes; Dizocilpine Maleate; Epilepsy; Felbamate; Flumazenil; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Imidazoles; Lamotrigine; Phenylcarbamates; Propylene Glycols; Receptors, GABA-A; Triazines; Vigabatrin

1989
Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices.
    British journal of pharmacology, 2000, Volume: 130, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; Acetates; Amines; Animals; Aspartic Acid; Calcium; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamates; Male; Neostriatum; Neurons; Neurotransmitter Agents; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Potassium; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Synaptosomes; Tritium

2000
Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:3

    Topics: Acetates; Aged; Amines; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Survival; Creatine; Cyclohexanecarboxylic Acids; Energy Metabolism; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parietal Lobe; Reference Values; Treatment Outcome

2003
Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate.
    Journal of neurochemistry, 2005, Volume: 94, Issue:4

    Topics: Amines; Analgesics; Animals; Aspartic Acid; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Foot; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Injections, Intraperitoneal; Injections, Spinal; Male; Neuralgia; Rats; Rats, Long-Evans; Spinal Cord; Spinal Cord Compression

2005
Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes.
    Naunyn-Schmiedeberg's archives of pharmacology, 2009, Volume: 379, Issue:4

    Topics: Adolescent; Adult; Aged; Amines; Amino Acids, Cyclic; Anticonvulsants; Aspartic Acid; Calcium Channel Blockers; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Exocytosis; Female; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Infant; Isoleucine; Male; Middle Aged; Neocortex; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Oximes; Potassium; Pregabalin; Synaptosomes; Tacrolimus; Young Adult

2009
Brain α2δ-1-Bound NMDA Receptors Drive Calcineurin Inhibitor-Induced Hypertension.
    Circulation research, 2023, 09-15, Volume: 133, Issue:7

    Topics: Animals; Aspartic Acid; Brain; Calcineurin Inhibitors; Gabapentin; Hypertension; Mice; Rats; Receptors, N-Methyl-D-Aspartate; Tacrolimus

2023